Skip to main content
. 2022 Aug 10;13:941210. doi: 10.3389/fendo.2022.941210

Figure 2.

Figure 2

(A–D) Immunohistochemistry staining of Ki67 in available paired primary tumors and metastases, showing G1 increase to G2, G1 increase to G3, G2 increase to G3, and G2 decrease to G1, respectively. Magnification: 400×. (E) Association among clinicopathological characteristics, Ki67 index variation and grade changes. (a) Metachronous metastases showed higher Ki67 index variation than synchronous metastases. (b, c) Patients with AJCC 8th stage I/II showed higher frequency of grade increase, and G1/G2 increase to G3 than patients with AJCC 8th stage III/IV.